Search Count: 107
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2021-02-03 Classification: IMMUNE SYSTEM Ligands: MAN, NAG, U57 |
 |
N-Terminal Bromodomain Of Human Brd2 With N-((4-(3-(N-Cyclopentylsulfamoyl)-4-Methylphenyl)-3-Methylisoxazol-5-Yl)Methyl)Acetamide Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2019-01-23 Classification: transcription/transcription inhibitor Ligands: JWA |
 |
N-Terminal Bromodomain Of Human Brd2 In Complex With 4,4'-(Quinoline-5,7-Diyl)Bis(3,5-Dimethylisoxazole) Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2019-01-23 Classification: transcription/transcription inhibitor Ligands: JWD, SO4 |
 |
N-Terminal Bromodomain Of Human Brd2 In Complex With N-Cyclopentyl-7-(3,5-Dimethylisoxazol-4-Yl)Quinoline-5-Sulfonamide Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2019-01-23 Classification: transcription/transcription inhibitor Ligands: JVY |
 |
C-Terminal Bromodomain Of Human Brd2 In Complex With 4-(2-Cyclopropyl-7-(6-Methylquinolin-5-Yl)-1H-Benzo[D]Imidazol-5-Yl)-3,5-Dimethylisoxazole Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.27 Å Release Date: 2019-01-23 Classification: transcription/transcription inhibitor Ligands: JW4, GOL |
 |
Discovery Of A Potent Cyclophilin Inhibitor (Compound 3) Based On Structural Simplification Of Sanglifehrin A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2017-01-25 Classification: isomerase/isomerase inhibitor Ligands: 7HG |
 |
Discovery Of A Potent Cyclophilin Inhibitor (Compound 5) Based On Structural Simplification Of Sanglifehrin A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2017-01-25 Classification: isomerase/isomerase inhibitor Ligands: 78E |
 |
Discovery Of A Potent Cyclophilin Inhibitor (Compound 6) Based On Structural Simplification Of Sanglifehrin A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2017-01-25 Classification: isomerase/isomerase inhibitor Ligands: 78R |
 |
Discovery Of A Potent Cyclophilin Inhibitor (Compound 7) Based On Structural Simplification Of Sanglifehrin A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.48 Å Release Date: 2017-01-25 Classification: isomerase/isomerase inhibitor Ligands: 78X |
 |
Discovery Of A Potent Cyclophilin Inhibitor (Compound 8) Based On Structural Simplification Of Sanglifehrin A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2017-01-25 Classification: isomerase/isomerase inhibitor Ligands: 838, SO4 |
 |
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION Resolution:3.10 Å Release Date: 2010-03-23 Classification: TRANSFERASE/DNA Ligands: SO4, MG |
 |
Hiv-1 Reverse Transcriptase-Dna Complex With Nuceotide Inhibitor Gs-9148-Diphosphate Bound In Nucleotide Site
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2010-03-23 Classification: TRANSFERASE/DNA Ligands: SO4, MG, 914 |
 |
Hiv-1 Reverse Transcriptase-Dna Complex With Datp Bound In The Nucleotide Binding Site
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION Resolution:2.90 Å Release Date: 2010-03-23 Classification: TRANSFERASE/DNA Ligands: SO4, MG, DTP |
 |
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION Resolution:2.90 Å Release Date: 2010-03-23 Classification: TRANSFERASE/DNA Ligands: MG, SO4 |
 |
Dissecting And Designing Inhibitor Selectivity Determinants At The S1 Site Using An Artificial Ala190 Protease (Ala190 Upa)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.68 Å Release Date: 2004-09-21 Classification: BLOOD CLOTTING, hydrolase Ligands: 696, CIT |
 |
Dissecting And Designing Inhibitor Selectivity Determinants At The S1 Site Using An Artificial Ala190 Protease (Ala190 Upa)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2004-09-21 Classification: BLOOD CLOTTING, hydrolase Ligands: ESI, CIT |
 |
Dissecting And Designing Inhibitor Selectivity Determinants At The S1 Site Using An Artificial Ala190 Protease (Ala190 Upa)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2004-09-21 Classification: BLOOD CLOTTING, hydrolase Ligands: CR9, CIT |
 |
Dissecting And Designing Inhibitor Selectivity Determinants At The S1 Site Using An Artificial Ala190 Protease (Ala190 Upa)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.05 Å Release Date: 2004-09-21 Classification: BLOOD CLOTTING, hydrolase Ligands: CR9 |
 |
Dissecting And Designing Inhibitor Selectivity Determinants At The S1 Site Using An Artificial Ala190 Protease (Ala190 Upa)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2004-09-21 Classification: serine protease, hydrolase Ligands: 132 |
 |
Dissecting And Designing Inhibitor Selectivity Determinants At The S1 Site Using An Artificial Ala190 Protease (Ala190 Upa)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2004-09-21 Classification: serine protease, hydrolase Ligands: CR9 |